The authors conclude that "the revised ICH Q2(R2) guideline updates terminology and broadens the scope of techniques/products applicable, improving validation requirements for uni- and multivariate analytical procedures, while maintaining traditional approaches." It also says that "while both Q14 and Q2(R2) align with principles outlined in USP <1220>, further clarity and alignment between the two guidelines are needed to promote a comprehensive lifecycle approach."
Monday, May 27, 2024
Advancements and knowledge gaps in ICH Q2(R2)
Starting with the relationship between ICH Q14 and Q2(R2), the authors take a critical look at the new aspects incorporated in ICH Q2(R2). The concepts of selectivity and specificity, range and response, as well as accuracy and precision are discussed in more detail. The authors also identify areas needing additional guidance and compare how the latest ICH Q14/Q2(R2) guidelines align with US pharmacopeial approaches.
Subscribe to:
Post Comments (Atom)
EU GMP Chapter 1 Revision: Key Updates and Stakeholder Consultation
The European Commission has announced a targeted revision to Chapter 1 of EudraLex Volume 4, the EU Good Manufacturing Practice (GMP) Guidel...
-
Access WL The recent FDA warning letter to an Indian manufacturer of active pharmaceutical ingredients (APIs) highlights major Good Manufact...
-
To conduct a **gap assessment** between the **old Schedule M** and the **revised Schedule M** of the **Drugs and Cosmetics Rules, 1945**, we...
No comments:
Post a Comment